December 16, 2021 |
Anheart Therapeutics Raises $61M in Series B for Precision Oncology Pipeline |
|
November 16, 2021 |
ACELYRIN, INC. Closes $250 Million Series B Financing and Announces Licensing of Izokibep |
|
October 26, 2021 |
Vertex signs another Mammoth-sized CRISPR deal with $650M in Biobucks on the Line |
|
September 24, 2021 |
Google Provider of At-home Covid-19 tests is Now a $3 Billion Company Traded on Nasdaq |
|
September 20, 2021 |
Pacific Biosciences Closes Acquisition of Omniome and Establishes San Diego Presence |
|
September 15, 2021 |
Alpine Immune Sciences Announces $91 Million Private Placement |
|
September 9, 2021 |
Mammoth Biosciences Raises $195 Million to Build Next-Generation CRISPR Products in Therapeutics and Diagnostics |
|
August 27, 2021 |
Lynk Pharmaceuticals Announces the Completion of Series B Financing of $50 Million |
|
August 26, 2021 |
Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement |
|
August 26, 2021 |
BeyondSpring Announces Exclusive Commercialization And Co-Development Agreement With Jiangsu Hengrui Pharmaceuticals For Plinabulin In Greater China |
|
August 24, 2021 |
Roche Tees up $3B+ for Shape's RNA Editing Platform |
|
August 18, 2021 |
Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test |
|
August 4, 2021 |
BeyondSpring Announces Positive Topline Results From Its DUBLIN-3 Rregistrational Trial Of Plinabulin in Combination with Docetaxel |
|
July 22, 2021 |
Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company |
|
July 20, 2021 |
Pacific Biosciences Signs Definitive Agreement to Acquire Omniome |
|
July 17, 2021 |
Shape Therapeutics Secures $112 Million in Series B Financing to Advance Breakthrough RNA Technology Platforms to Democratize Gene Therapy |
|
July 15, 2021 |
AnHeart Therapeutics Announces License Agreement with NewG Lab for Taletrectinib Rights in Korea |
|
July 14, 2021 |
Cellares and Poseida Therapeutics Partner to Accelerate Cell Therapy |
|
June 23, 2021 |
Adela Debuts with $60M in Series A Financing and a Breakthrough Approach to Blood-Based Detection of Cancer and Other Diseases |
|
June 2, 2021 |
SCYNEXIS Announces FDA Approval of BREXAFEMME® (ibrexafungerp tablets) as the First and Only Oral Non-Azole Treatment for Vaginal Yeast Infections |
|
May 31, 2021 |
Innovent Biologics and AnHeart Therapeutics Jointly Announce Exclusive License Agreement for Taletrectinib in Greater China |
|
May 27, 2021 |
GenapSys Rakes in $70M for Tabletop Genomic Sequencing Platform |
|
May 17, 2021 |
Hummingbird Bioscience Raises US$125 Million in Series C Financing |
|
May 17, 2021 |
Aerpio Pharmaceuticals and Aadi Bioscience Enter into a Definitive Merger Agreement |
|
May 13, 2021 |
Cue Health Announces Completion of $235 Million Private Financing to Accelerate Growth |
|
May 5, 2021 |
Cellares Raises $82M To Solve The Biggest Hurdles In Cell Therapy Manufacturing |
|
March 24, 2021 |
Bioheng Biotech Raised $80 million in Series B Financing to Advance Allogeneic Immuno-Cell Therapies |
|
March 23, 2021 |
EpimAb Biotherapeutics Raises $120M in Series C Financing to Advance Bispecific Programs and Broaden Clinical Pipeline |
|
March 5, 2021 |
FDA Authorizes Cue Health’s COVID-19 Test for At-Home and Over The Counter Use |
|
February 10, 2021 |
Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth |
|
February 10, 2021 |
Terns Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares |
|
February 5, 2021 |
Equillium Announces Closing of $30 Million Registered Direct Offering |
|
January 6, 2021 |
LevitasBio Raises $18M in Series B Financing, Forms JV With Thalys Medical in China |
|
January 5, 2021 |
Lilly-backed Terns raises $87M for multi-front assault on NASH |
|